Using 3-D spectral-spatial excitation, the center frequency of the spectral passband can be varied as a function of two spatial coordinates. Such variation could be tailored to field map data to compensate for b0 shifts. The 3-D excitation has 3-D spiral trajectories in k-space.
|
10. A magnetic resonance imaging method of selective nuclei excitation in an object in the presence of an inhomogeneous magnetic field through said object comprising the step of applying a three-dimensional spectral-spatial excitation in which the center frequency of a spectral passband is varied as a function of two spatial coordinates.
13. Apparatus for selectively exciting nuclei in an object for magnetic resonance imaging comprising
means for applying a static magnetic field b0 through said object, and means for applying rf excitation pulses to said object which are spatially selective along two axes and spectrally selective whereby effects of spectral shifts due to inhomogeneity of said static magnetic field are compensated by said rf pulses.
1. A method of selectively exciting nuclei in an object for magnetic resonance imaging comprising the steps of
applying a static magnetic field b0 through said object, and applying an rf excitation pulse to said object which is spatially selective along two axes and spectrally selective in chemical shift whereby arbitrarily specified excitation profiles, with arbitrarily specified magnitude and phase, in two spatial dimensions and one spectral dimension are achieved.
2. The method as defined by
3. The method as defined by
4. The method as defined by
5. The method as defined by
6. The method as defined by
8. The method defined by
9. The method defined by
11. The method as defined by
12. The method as defined in
14. Apparatus as defined by
15. Apparatus as defined by
16. Apparatus as defined by
|
The U.S. Government has rights in the disclosed invention pursuant to NIH Grant No. CA-48269 and NIGMS No. 5&32GM07365 to Stanford University.
This invention relates generally to Magnetic Resonance Imaging (MRI) and more particularly the invention relates to the spectral-spatial magnetic excitation selective simultaneously in two spatial dimensions and in the spectral (i.e. chemical shift) dimension.
Magnetic resonance imaging (MRI) is a non-destructive method for the analysis of materials and represents a new approach to medical imaging. It is generally noninvasive and does not involve ionizing radiation. In very general terms, nuclear magnetic moments are excited at specific spin precession frequencies which are proportional to the local magnetic field. The radio-frequency signals resulting from the precession of these spins are received using pickup coils. By manipulating the magnetic fields, an array of signals is provided representing different regions of the volume. These are combined to produce a volumetric image of the nuclear spin density of the body.
Spectrally selective pulses are used to image selected components in an object, such as fat and water, or to image metabolites with very low density such as N-acetyl aspartate (NAA), creatine, and choline in the presence of fat and water. However, due to the small chemical shift between individual components (fat and NAA, for example), inhomogeneities in the magnetic field can cause undesired signals to be imaged while wanted signal components move out of the excitation passband. This is a particular problem in "fat saturation," where fat is selectively excited and dephased prior to excitation and imaging of water. Inhomogeneity in the static field, B0, can cause fat to fall outside the excitation passband or cause water to fall inside the passband, resulting in lack of suppression of fat signal or undesired suppression of water signal. Inhomogeneity is also a problem in spectroscopic imaging in the frontal and temporal lobes of the brain where broad magnetic shifts in the static field, B0, can cause fat or water to enter the passband of a spectrally selective excitation intended to excite, for instance, only NAA, or cause NAA signals to fall outside of the spectral passband.
The use of k-space trajectories for selective excitation in three spatial dimensions is heretofore known. See Pauly, U.S. Pat. No. 5,270,653, for example. The present invention is directed to using three-dimensional k-space trajectories for a spectral-spatial excitation where two dimensions are spatial and the third is the spectral or chemical shift dimension. Specifically, the center frequency of a spectral passband is varied as a function of two spatial coordinates.
In accordance with the invention, simultaneous excitation in two spatial dimensions and one spectral (chemical shift) dimension is provided using k-space trajectories. Desired excitation profiles, arbitrary in phase and magnitude, are achieved simultaneously (i.e. with a single RF pulse) in two spatial dimensions and in the chemical shift dimension, with resolution in all three dimensions limited by gradient hardware capabilities and pulse length. Specifically, an excitation profile of constant shape in the chemical shift dimension is specified. The center frequency of the excitation is varied across a two-dimensional plane by varying the RF excitation to readily correct for main field inhomogeneities.
The invention has proved to be particularly applicable in spectroscopic imaging in areas of poor main field homogeneity, such as the frontal lobes of the brain. The invention has also proved to be particularly applicable in fat suppression in areas of poor main field homogeneity, such as the knees, abdomen, and breast.
The invention and objects and features thereof will be more readily apparent from the following detailed description and appended claims when taken with the drawing.
FIGS. 1A-1D illustrate the arrangement of conventional MRI apparatus and magnetic fields generated therein.
FIG. 2 is a functional block diagram of MRI imaging apparatus.
FIGS. 3A, 3B illustrate a single kx, ky trajectory and a complete kx,ky,k-omega trajectory in accordance with the invention.
FIGS. 4A, 4B, and 4C illustrate three planes of the magnitude portion of a desired 3-D excitation whose phase portion is zero.
FIGS. 5A, 5B illustrate two planes of the actual resulting excitation.
Referring now to the drawings, FIG. 1A is a perspective view, partially in section, illustrating coiled apparatus in an NMR imaging system, and FIGS. 1B-1D illustrate field gradients which are produced in the apparatus of FIG. 1A. This apparatus is discussed by Hinshaw and Lent, "An Introduction to NMR Imaging: From the Bloch Equation to the Imaging Equation," Proceedings of the IEEE, Vol. 71, No. 3, March 1983, pp. 338-350. Briefly, the uniform static field of B0 is generated by the magnet comprising the coil pair 10. A gradient field Gx is generated by a complex gradient coil set which can be wound on the cylinder 12. An RF field B1 is generated by a saddle coil 14. A patient undergoing imaging would be positioned along the Z axis within the saddle coil 14.
In FIG. 1B an X gradient field is shown which is parallel to the static field B0 and varies linearly with distance along the X axis but which does not vary with distance along the Y and Z axes. FIGS. 1C and 1D are similar representations of the Y gradient and Z gradient fields, respectively.
FIG. 2 is a functional block diagram of the imaging apparatus as disclosed in "NMR-A Perspective on Imaging," General Electric Company, 1982. A computer 20 is programmed to control the operation of the NMR apparatus and process free induction decay (FID) signals detected therefrom. The gradient field is energized by a gradient amplifier 22, and the RF coils for impressing an RF magnetic moment at the Larmor frequency is controlled by the transmitter 24 and the RF coils 26. After the selected nuclei have been flipped, the RF coils 26 are employed to detect the FID signal which is passed to the receiver 28 and thence through digitizer 30 for processing by computer 20.
As noted above, spectrally selective pulses are used to image selected components in an object, such as fat or water, or metabolites such as NAA present in very small concentrations in the presence of fat and water. The present invention overcomes the problem of shifts in the resonant frequency of individual components such as water, fat, or NAA due to inhomogeneities in the static magnetic field. Two specific examples are fat suppression and spectroscopic imaging. In fat suppression in areas of poor main field homogeneity such as the knee, abdomen, and breast, inhomogeneity can cause fat to fall out of the excitation passband and be inadequately excited, or water to fall into the passband and be undesirably excited. In spectroscopic imaging, main field inhomogeneity can cause desired signals such as NAA to fall out of the spectral passband and be poorly excited, and undesired signals such as fat and water to fall within the passband and be poorly suppressed. Using a 3-D spectral-spatial excitation, the center frequency of the spectral passband is varied as a function of two spatial coordinates, and the variation is tailored to field map data to compensate for B0 shifts, thus allowing simultaneous fat and water suppression with a 3-D spectral spatial pulse in spectroscopic imaging, and complete fat suppression in fat suppression imaging.
In accordance with one embodiment, the excitation k-space trajectory is a sequence of spirals such as the single spiral kx,ky trajectory of FIG. 3A, repeated in time to give the complete trajectory kx,ky,k-omega of FIG. 3B. To achieve a spectral field of view of 320 Hz, the trajectory is constrained to repeat in kx and ky every 3.125 milliseconds. Under this constraint and the gradient constraints of a 1.5 Tesla GE Signa 5.3 system, a spiral of about 41/2 turns is possible with a spatial field of view of 24 cm. This gives a spatial resolution of about 2.7 cm.
To create the RF waveform, the desired excitation profile in x,y and omega is represented on a 128×128×128 grid. The excitation is transformed to k-space by 3-D FFT. The values of the RF waveform are sampled off of the resulting k-space grid along the excitation trajectory, scaled by gradient strength. No constraints are placed on the desired excitation in terms of symmetry or realness. The RF waveform is generally complex, necessitating control of both magnitude and phase of the RF pulse.
Spectral-spatial excitation is often complicated by "half-Nyquist" aliasing lobes caused by non-uniform sampling in the frequency dimension. Because the trajectory samples uniformly along the omega axis, no "half-Nyquist" lobes appear, even though sampled points are not on planes of constant k-omega.
To demonstrate the feasibility of 3-D spectral-spatial excitation with standard gradients, a test excitation is applied to a water phantom. The excitation consists of a target and a ring at different resonant frequencies, as depicted in FIG. 4. The FOV is 320 Hz by 24 cm by 24 cm. Experimental results obtained with a GE Signa 1.5 Tesla magnet are shown in FIG. 5 at two different frequencies.
A resolution of 2.7 cm allows compensation for only gradual B0 shifts. However, faster gradients, possibly employing trajectory shapes other than spirals, will allow finer resolution and wider spectral FOV. A gradient 10 times faster than the system employed above would allow spatial resolution of under 1 cm.
Spiral k-space trajectories allow the design of excitation pulses selective spectrally and in two spatial dimensions. Usable resolution is obtained in all three dimensions with standard gradient hardware. Subject to resolution constraints, arbitrary complex excitations may be achieved.
While the invention has been described with reference to a specific embodiment, the description is illustrative of the invention and is not to be construed as limiting the invention.
Various modifications and applications may occur to those skilled in the art without departing from the true spirit and scope of the invention as defined by the appended claims. Specifically, k-space trajectories other than spirals, such as those constructed of trapezoids or so-called "echo planar" trajectories, fall in the scope of the invention.
Patent | Priority | Assignee | Title |
10012713, | Jul 30 2013 | SIEMENS HEALTHINEERS AG | Method and device for determination of a magnetic resonance control sequence |
10955506, | Mar 09 2018 | KONINKLIJKE PHLIPS N V | Parallel MR imaging with spectral fat suppression |
5755666, | Jul 20 1995 | U S PHILIPS CORPORATION | Method and device for imaging a curved region by means of magnetic resonance |
6781373, | Nov 26 2002 | GE Medical Systems Global Technology Company, LLC | Water chopped dual-band selective excitation |
7271385, | Jun 21 2002 | Hitachi High-Technologies Corporation | Inspection method and inspection apparatus using electron beam |
7289840, | Sep 22 2004 | Receptomon, LLC | Method for monitoring early treatment response |
7622102, | Feb 08 2005 | Receptomon, LLC | Method for monitoring early treatment response |
7663365, | Sep 28 2007 | Toshiba Medical Systems Corporation | Magnetic resonance imaging apparatus and analysis method for fat suppression effect in magnetic resonance imaging apparatus |
7771706, | Feb 08 2005 | Receptomon, LLC | Method for monitoring protein translation |
7952354, | Nov 21 2006 | General Electric Company | System and method for fast MR imaging of metabolites at selective excitation frequencies |
8131337, | Apr 05 2005 | Receptomon, LLC | Method for monitoring early treatment response |
8197795, | Sep 22 2004 | Receptomon, LLC | Method for monitoring early treatment response |
Patent | Priority | Assignee | Title |
4628262, | Feb 05 1985 | AURORA IMAGING TECHNOLOGY, INC | Multiple echo chemical shift imaging |
4881032, | Oct 21 1988 | General Electric Company | Method of, and apparatus for, NMR spectroscopic metabolite imaging and quantification |
4902973, | Mar 27 1987 | GENERAL ELECTRIC MEDICAL SYSTEMS ISRAEL LTD , AN ISRAEL CORPORATION AFFILIATED WITH GENERAL ELECTRIC COMPANY | Separation of spectral components |
4985677, | Jun 22 1989 | The Board of Trustees of the Leland Stanford Junior University | Magnetic resonance imaging and spectroscopy using an excitation pulse for multiple-dimensional selectivity |
4999580, | Jun 20 1989 | The Board of Trustees of the Leland Stanford Junior University | magnetic resonance imaging and spectroscopy using a single excitation pulse for simultaneous spatial and spectral selectivity |
5162736, | Aug 14 1987 | British Technology Group Limited | NMR imaging |
5233301, | Jul 28 1989 | Board of Trustees of the Leland Stanford Junior University | High resolution/reduced slice width magnetic resonance imaging and spectroscopy by signal combination and use of minimum phase excitation pulses |
5245282, | Jun 28 1991 | University of Virginia Patent Foundation | Three-dimensional magnetic resonance imaging |
5270653, | Apr 10 1992 | The Board of Trustees of the Leland Stanford Junior University; BOARD OF TRUSTEES OF THE LELAND STANDFORD JUNIOR UNIVERSITY, THE | Selective three dimensional excitation for magnetic resonance applications |
5275164, | Aug 10 1988 | Hitachi, Ltd. | Multi-dimensional magnetic resonance imaging method and apparatus for same |
5283526, | Jul 01 1992 | Board of Trustees of the Leland Stanford Junior University | Method for performing single and multiple slice magnetic resonance spectroscopic imaging |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 06 1995 | MORRELL, GLEN ROBERT | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY OFFICE OF TECHNOLOGY LICENSING | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 007305 | /0778 | |
Jan 10 1995 | Board of Trustees of the Leland Stanford Junior University | (assignment on the face of the patent) | / | |||
Mar 21 1995 | Stanford University | NATIONAL INSTITUTES OF HEALTH NIH , U S DEPT OF HEALTH AND HUMAN SERVICES DHHS , U S GOVERNMENT | CONFIRMATORY LICENSE SEE DOCUMENT FOR DETAILS | 024756 | /0903 |
Date | Maintenance Fee Events |
Jun 20 2000 | REM: Maintenance Fee Reminder Mailed. |
Nov 26 2000 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Dec 22 2003 | ASPN: Payor Number Assigned. |
Date | Maintenance Schedule |
Nov 26 1999 | 4 years fee payment window open |
May 26 2000 | 6 months grace period start (w surcharge) |
Nov 26 2000 | patent expiry (for year 4) |
Nov 26 2002 | 2 years to revive unintentionally abandoned end. (for year 4) |
Nov 26 2003 | 8 years fee payment window open |
May 26 2004 | 6 months grace period start (w surcharge) |
Nov 26 2004 | patent expiry (for year 8) |
Nov 26 2006 | 2 years to revive unintentionally abandoned end. (for year 8) |
Nov 26 2007 | 12 years fee payment window open |
May 26 2008 | 6 months grace period start (w surcharge) |
Nov 26 2008 | patent expiry (for year 12) |
Nov 26 2010 | 2 years to revive unintentionally abandoned end. (for year 12) |